51. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. Issue 1 (January 2020) Authors: Hegele, Robert A; Borén, Jan; Ginsberg, Henry N; Arca, Marcello; Averna, Maurizio; Binder, Christoph J; Calabresi, Laura; Chapman, M John; Cuchel, Marina; von Eckardstein, Arnold; Frikke-Schmidt, Ruth; Gaudet, Daniel; Hovingh, G Kees; Kronenberg, Florian; Lütjohann, Dieter; Parhofer, Klaus G; Raa... Journal: Lancet Issue: Volume 8:Issue 1(2020) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)". Issue 6 (6th February 2018) Authors: Kusters, D. Meeike; Braamskamp, Marjet J.A.M.; Langslet, Gisle; McCrindle, Brian W.; Cassiman, David; Francis, Gordon A.; Gagne, Claude; Gaudet, Daniel; Morrison, Katherine M.; Wiegman, Albert; Turner, Traci; Miller, Elinor; Raichlen, Joel; Martin, Paul D.; Stein, Evan A.; Kastelein, John J.P.; H... Journal: Circulation Issue: Volume 137:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia. Issue 5 (4th May 2019) Authors: Khoury, Etienne; Brisson, Diane; Roy, Nathalie; Tremblay, Gérald; Gaudet, Daniel Journal: Expert opinion on drug safety Issue: Volume 18:Issue 5(2019) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study. (30th November 2020) Authors: Gaudet, Daniel; López-Sendón, José Luis; Averna, Maurizio; Bigot, Grégory; Banach, Maciej; Letierce, Alexia; Loy, Megan; Samuel, Rita; Manvelian, Garen; Batsu, Isabela; Henry, Patrick Journal: European journal of preventive cardiology Issue: Volume 28:Number 17(2021) Page Start: 1864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia: a single-arm, open-label, proof-of-concept study. (August 2017) Authors: Gaudet, Daniel; Gipe, Daniel; Hovingh, Kees; Ahmad, Zahid; Cuchel, Marina; Shah, Prediman; Chyu, Kuang -Yuh; Pordy, Robert; Sasiela, William; Chan, Kuo -Chen; Khoury, Etienne Journal: Atherosclerosis Issue: Volume 263(2017) Page Start: e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. SARS–CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking. (2nd January 2021) Authors: Hamet, Pavel; Pausova, Zdenka; Attaoua, Redha; Hishmih, Camil; Haloui, Mounsif; Shin, Jean; Paus, Tomas; Abrahamowicz, Michal; Gaudet, Daniel; Santucci, Lara; Kotchen, Theodore A; Cowley, Allen W; Hussin, Julie; Tremblay, Johanne Journal: American journal of hypertension Issue: Volume 34:Number 4(2021) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. Sex Differences in Blood Pressure Hemodynamics in Middle-Aged Adults With Overweight and Obesity. Issue 2 (August 2019) Authors: Syme, Catriona; Shin, Jean; Richer, Louis; Gaudet, Daniel; Paus, Tomáš; Pausova, Zdenka Journal: Hypertension Issue: Volume 74:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Surviving Familial Hypercholesterolemia without Coronary Artery Disease: A Unique Phenomenon Associated with Newly Identified Biological and Genetic Markers. (June 2018) Authors: Khoury, Etienne; Brisson, Diane; Roy, Nathalie; Tremblay, Gérald; Gaudet, Daniel Journal: Atherosclerosis Issue: Volume 32(2018) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS). (August 2017) Authors: Gaudet, Daniel; Digenio, Andres; Alexander, Vickie; Arca, Marcello; Jones, Alan; Stroes, Erik; Bergeron, Jean; Civeira, Ferdando; Hemphill, Linda; Blom, Dirk; Flaim, Joann; Hughes, Steven; Geary, Richard; Tsimikas, Sotirios; Witztum, Joseph; Bruckert, Eric Journal: Atherosclerosis Issue: Volume 263(2017) Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS. (June 2018) Authors: Gaudet, Daniel; Digenio, Andres; Alexander, Veronica J.; Arca, Marcello; Jones, Alan F.; Stroes, Erik; Bergeron, Jean; Civeira, Fernando; Hemphill, Linda C.; Blom, Dirk J.; Flaim, Joann; Hughes, Steven; Geary, Richard; Tsimikas, Sotirios; Bruckert, Eric Journal: Atherosclerosis Issue: Volume 32(2018) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗